Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Yuebing Li, MD, PhD

216.444.5559

Yuebing Li, MD, PhD

Appointed: 2012

Yuebing Li, MD, PhD
Department: Neuromuscular Center
Location: Cleveland Clinic Main Campus
Mail Code S90
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5559
DeskDesk:216.444.5551
WorkFax:216.445.1563
Yuebing Li, MD, PhD
Department: Neurology
Location: Cleveland Clinic Main Campus
Mail Code S90
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5559
DeskDesk:216.444.5551
WorkFax:216.445.1563
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

1. Li Y,. Remmel K. Relapsing polyradiculoneuropathy as a neurological manifestation of systemic lupus erythematosus. Muscle and Nerve. 2012, 46(5): 828-829.

2Li, Y., Gor D., Walicki D., Jenny D., Jones D., Barbour P., Castaldo J. The Spectrum and Potential Pathogenesis of Reversible Posterior Leukoencephalopathy Syndrome. Manuscript accepted by Journal of Stroke and Cerebrovascular Diseases 2012, 21(8): 873-882.

3. Li Y., Isayev Y., Li Y. Spinal hemorrhage leading to cerebral vasospasm and infarction. Journal of Neurology Research 2012; 2(4): 164-167.

4. Li Y,. Remmel K. A case of monomelic amyotrophy of the upper limb: MRI findings and the implication on its pathogenesis. Journal of Clinical Neuromuscular Diseases 2012; 13(4): 234-239.

5. Li Y., Jenny D., Castaldo J. Posterior reversible encephalopathy syndrome: Clinicoradiological spectrum, early recognition and therapeutic strategies. Hospital Practice. 2012; 40 (1): 202-213.

6. Li Y., Margraf J., Kluck B., Jenny D., Castaldo J. Thrombolytic Therapy for Ischemic Stroke Secondary to Paradoxical Embolism in Pregnancy, a Case Report and Literature Review. Neurologist. 2012;18(1):44-8.

7. Nwoke F. and Li, Y. Focal thalamic and cortical magnetic response changes associated with partial status epilepticus. Journal of Neurology Research 2011; 1(4):170-174.

8. Li Y., Castaldo J, Van der Hetden J, Plokker H. Is carotid artery disease responsible for perioperative strokes after coronary artery bypass surgery? Journal of Vascular Surgery 2010; 52: 1716-1721.

9. Li Y., Castaldo J. Carotid disease is rarely responsible for stroke after coronary bypass surgery. European Journal of Vascular Endovascular Surgery 2010; 40: 689-693

10. Li Y., Jenny D, Castaldo J. Cardiac surgery, carotid stenosis and stroke prevention. Hospital Practice 2010; 38: 29-39.

11. Li Y., Jenny D, Bemporad J., Castaldo J. Sulcal artery syndrome following vertebral artery dissection. Journal of Stroke and Cerebrovascular Diseases 2010; 19: 333-335.

12. Li Y., Clauser D., Jenny D., Castaldo J. Falsely disappearing stroke secondary to isodense subdural hematoma. Neurology 2010; 74: e15.

13. Li Y., Walicki D., Mathiesen C., Jenny D., Li Q., Isayev Y., Reed J., Castaldo J. Strokes following open heart surgery and carotid artery stenosis. Archives of Neurology 2009; 66(9): 1091-1096.

14. Amin A, Li Y., Finkelstein R. Identification of a Drosophila prolyl endopeptidase and analysis of its expression. DNA and Cell Biology 1999;18: 605-610.

15. Amin A, Li Y., Finkelstein R. Hedgehog activates the EGF receptor pathway during Drosophila head development. Development 1999; 126: 2623-2630.

16. Li Y., Finkelstein R., 1998. A screen for the modified orthodenticle function in the adult fly head. Ph.D. thesis. University of Pennsylvania.

17. Li Y., Musacchio M, Finkelstein R. A homologue of the calcium-binding disulfide isomerase CaBP1 is expressed in the developing CNS of Drosophila melanogaster. Developmental Genetics 1998; 23: 104-110.

18. Li Y., Brown S., Denell R., and Finkelstein R. Two orthodenticle-related genes in the short-germ beetle Tribolium castaneum. Development, Genes and Evolution 1996; 206: 35-45.

19. Lindstrom J., Anand R, Peng X, Gerzanich V., Wang F., Li Y.Neuronal nicotinic receptor subtypes. Annals of the New York Academy of Sciences 1995; 757: 100-116.

20. Li Y., Allede M., Finkelstein R., and Weinberg E. Expression of two zebrafish orthodenticle-related genes in the embryonic brain. Mechanism of Development 1994; 48: 229-244.

21. Yang J., Xu K.M., Yang W.M., Li Y., Zhang Z.J. Normal variations of median-nerve somatosensory evoked potentials in children. Chinese Medical Journal 1991; 71: 560-565.

22. Li Y., and Xu K.M. P 300 cognitive evoked potentials and its application in pediatric neurology and psychology. Foreign Medicine: Pediatrics 1991; 18: 116-119.

23. Li Y., and Xu K.M. Auditory brainstem responses in normal childhood and high-risk newborns. Chinese Medical Journal 1990; 70: 642-645.

24. Li Y, Xu K.M. Application of auditory brainstem responses in high-risk neonates. Chinese Journal of Neonatal Medicine 1989; 4: 281-284.

Education & Fellowships

Fellowship - University of Cincinnati Medical Center/University Hospital
Clinical Neurophysiology
Cincinnati, OH USA
2003
Residency - University of Cincinnati Medical Center/University Hospital
Neurology
Cincinnati, OH USA
2002
Internship - The Christ Hospital
Medicine
Cincinnati, OH USA
1999
Doctorate - University of Pennsylvania School of Medicine
Philadelphia, PA USA
1998
Medical School - Qingdao Medical College
Shandong China
1986

Certifications

  • American Board of Electrodiagnostic Medicine
  • Neurology

Specialty Interests

Autoimmune Polyneuropathy Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Dermatomyositis Inclusion Body Myositis (IBM) Inherited Neuropathies Muscular Dystrophy Myasthenia Gravis Myopathy Plexopathy Polymyositis

Memberships

  • Member, American Academy of Neurology
  • Member, American Academy of Neuromuscular and  Electrodiagnostic Medicine

Treatment & Services

  • Clinical Evaluation, Diagnosis And Treatment
  • Electromyography
  • Inflammatory/Autoimmune Neuropathy
  • Nerve Conduction Studies

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/15/2014, Dr. Li has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English